semaglutide banned in california The FDA has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, patients who took its GLP-1 medications, popularly known as Ozempic and Popular weight loss drugs Ozempic

Explore alternative medications Zepbound Zepbound (Tirzepatide) is an injectable medicine for weight loss that helps control sugar levels and curb appetite for chronic weight management

LDL apheresis should be considered in patients with high Lp(a) concentration and signs of rapid progression of atherosclerosis

Annie Moore, an internal medicine doctor who is board-certified in obesity medicine and has extensive experience prescribing GLP-1 weight loss medications to her patients

their association with SGLT-2 inhibitors requires further confirmation through large, randomized trials ( SGLT2 inhibitors should be discontinued in specific clinical scenarios to mitigate potential adverse events